Novozymes Total Non-Operating Income/Expense 2011-2023 | NVZMY
Novozymes total non-operating income/expense for the twelve months ending December 31, 2023 was $-0.010B, a 1274.01% increase year-over-year.
- Novozymes annual total non-operating income/expense for 2023 was $-0.01B, a 1274.01% increase from 2022.
- Novozymes annual total non-operating income/expense for 2022 was $-0.001B, a 94.64% decline from 2021.
- Novozymes annual total non-operating income/expense for 2021 was $-0.013B, a 34.2% decline from 2020.